A prognostic gene expression signature in infratentorial ependymoma.
about
The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research PerspectiveMolecular Markers in Low-Grade Glioma-Toward Tumor ReclassificationTelomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.Epigenomic alterations define lethal CIMP-positive ependymomas of infancyDisrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like featuresPediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.Infratentorial ependymomas--a study of the centre in KatowiceDelayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions.Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A EpendymomaGenetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsThe Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.Descriptive epidemiology of ependymal tumours in the United StatesBiology and management of ependymomas.The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymomaSpinal cord ependymomas in children and adolescents.Current and evolving knowledge of prognostic factors for pediatric ependymomas.Emerging insights into the ependymoma epigenome.Multidisciplinary management of pediatric intracranial ependymoma.Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.Molecular biology of pediatric brain tumors and impact on novel therapies.Posterior fossa ependymoma: current insights.Advances in Management of Pediatric Ependymomas.Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives.Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.Molecular pathology of paediatric central nervous system tumours.Characterization of gliomas: from morphology to molecules.Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system.NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma.EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.microRNA network analysis identifies miR-29 cluster as key regulator of LAMA2 in ependymomaToward an integrated histomolecular diagnosis of supratentorial ependymoma.
P2860
Q26766642-A37E789A-1A11-4D19-9DF0-15D65995EDECQ28383205-3DAA5BE4-9A17-4E33-B8C5-A96FC181B701Q30613404-C8756428-CE9F-458D-9D6C-2AEDDE7EAAFAQ34240198-3E2FF01E-69EE-404C-BF00-4C1EE761821EQ34553348-C6D593CF-D758-4BA4-81F8-323DEB9D42FAQ35450056-84467307-5B5D-414F-932C-E6184EBD3EF1Q35604841-DA264F71-6D71-4269-A491-A4892D5FB4C4Q35754390-46BD38BA-5E6D-4F22-A474-D10860E495E3Q35788894-0DEC3A22-CD85-4705-B1AF-984F76431409Q35825515-8F1A1CF1-2373-4F78-B062-8B58A6CDF4FBQ35832560-D1494751-482B-4065-AE4A-1893C6071D6CQ35958168-0718F54C-7595-4C07-ABE5-E5426E098FFAQ36070798-0B129C42-A12B-4C67-9341-E619EB4E0DB6Q36132647-12ADF40D-7354-428D-9B07-0FADB5E810BAQ36135966-7DF6F462-FEDF-49C8-A8D9-298C342BA1EFQ36461766-57017375-14D5-4ECC-9EF3-8853F0B155D7Q36753692-394E4C10-CDF8-4EED-A7BA-FB0051C3F264Q36892843-175F26E4-3817-4B77-A2CA-5E3974EE9CC2Q36924756-7C0A5294-47A0-4F1F-B9D5-06326817E35CQ36977704-DC86B927-3445-4178-8951-472B75D00BB3Q37553466-3B5EC72D-E00A-438A-B0BA-2E069FF281DEQ37705192-841EAF04-62F5-4904-9FBC-B33DEDE356F3Q38041984-51F4BF91-9B05-41BD-A381-7412F0DF134FQ38081982-3F815B50-7505-4EA4-BAA5-581952DF2E4BQ38083798-3936FAED-8878-4ED9-AEA3-22249C14F789Q38233102-CF94AEAE-3E77-4FE3-B237-34617C8D84F5Q38245575-649F219B-B8E8-483E-AD13-5FC54EF203ACQ38359284-7D4D4864-4D54-42BC-9E9B-A4E2F5B27401Q38583252-09F81591-124E-40A3-A625-2215F76E75B4Q38586580-157598A0-2D70-4EFD-84F3-3BE384304741Q38681915-23D83E57-11C6-490B-836F-71BD0204F37FQ38834470-87D0A550-0494-4736-B959-E926AF6F7B47Q38971961-3670146A-4CFF-4577-9A3D-E5BB5ACA2261Q39412967-AC30B7AC-CDAC-45C3-BE5B-CD9EAEF6C13BQ39451532-E2DD3876-B868-44A6-83E0-A238968A9E27Q39459076-3319116E-CF0A-429C-8E81-8C750135D993Q40199358-F8209D42-2291-4B3F-BA0A-136CCE2D6029Q42175070-8D091AF4-7205-4DB4-92DF-7FE92810DB5DQ42562689-7C32F847-E128-428B-971F-CA1A3125065CQ42738552-8B781C05-33CC-455C-BC75-638D7E11605A
P2860
A prognostic gene expression signature in infratentorial ependymoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A prognostic gene expression signature in infratentorial ependymoma.
@ast
A prognostic gene expression signature in infratentorial ependymoma.
@en
A prognostic gene expression signature in infratentorial ependymoma.
@nl
type
label
A prognostic gene expression signature in infratentorial ependymoma.
@ast
A prognostic gene expression signature in infratentorial ependymoma.
@en
A prognostic gene expression signature in infratentorial ependymoma.
@nl
prefLabel
A prognostic gene expression signature in infratentorial ependymoma.
@ast
A prognostic gene expression signature in infratentorial ependymoma.
@en
A prognostic gene expression signature in infratentorial ependymoma.
@nl
P2093
P2860
P1476
A prognostic gene expression signature in infratentorial ependymoma.
@en
P2093
Aditya Raghunathan
Alicia Ledoux
Brian Vaillant
Charmaine Wilson
Collaborative Ependymoma Research Network
David Ellison
Elizabeth Vera-Bolanos
Ian Pollack
Ken Aldape
Khalida Wani
P2860
P2888
P304
P356
10.1007/S00401-012-0941-4
P577
2012-02-10T00:00:00Z
P6179
1003579595